We have previously found poor agreement between Henderson-Hasselbalch and enzymatic methods for estimating plasma bicarbonate concentration in critically ill patients. In this study we compared these two established methods with a new method for estimating bicarbonate using the strong-ion-gap equation. The strong-ion-gap is derived from the Stewart approach to acid-base physiology. One hundred data sets were collected from records of routine daily blood samples in critically ill patients. Bland-Altman analyses were used to compare the three methods. We proposed that bias greater than ±1 mmol/l and limits of agreement wider than bias ±2 mmol/l were clinically important. Comparing the Henderson-Hasselbalch method to the enzymatic method, the bias was 2.1 mmol/l and the limits of agreement were -1.8 mmol/l to 5.9 mmol/l. Comparing the Henderson-Hasselbalch method to the strong-ion-gap method, the bias was -9.1 mmol/l and the limits of agreement were -17.1 mmol/l to -1.1 mmol/l. Comparing the enzymatic to the strong-ion-gap method, the bias was -11.2 mmol/l and the limits of agreement were -18.2 mmol/l to -4.2 mmol/l. This study found poor agreement between the two established bicarbonate assays and worse agreement between the established assays and the strong-ion-gap method. The strong-ion-gap method is currently too inaccurate for clinical application, but may have future use.
Several research groups have questioned the reliability of the constants in the Henderson-Hasselbalch equation when used to estimate plasma bicarbonate concentration. This particularly applies to plasma from critically ill patients 1 . Another way to estimate plasma bicarbonate is to measure total carbon dioxide. This method is undermined by loss of carbon dioxide to the atmosphere 2 . Comparing the Henderson-Hasselbalch method and an enzymatic method of determining total carbon dioxide, we have previously shown poor agreement in estimating plasma bicarbonate concentration in the critically ill 3 .
The Stewart approach to acid-base physiology provides another method to estimate the plasma bicarbonate concentration by manipulating the strong-ion-gap equation 4 . This method has not been examined. Using data from a recent study 5 of acidbase disorders in critically ill patients, we asked, what is the agreement in estimating plasma bicarbonate concentration between the Henderson-Hasselbalch, enzymatic, and strong-ion-gap methods?
METHODS Data were prospectively collected from Intensive Care Unit records at the Austin and Repatriation Medical Centre, a tertiary referral hospital affiliated with The University of Melbourne. All samples were routine morning samples taken from arterial lines in patients requiring intensive care management. No additional sampling was required and collected data did not identify patients. The Austin and Repatriation Medical Centre Human Research Ethics Committee waived the need for informed consent.
Arterial blood samples were collected in heparinized blood-gas syringes (Rapidlyte, Chiron Diagnostics, East Walpole, MA, U.S.A.) and were immediately analyzed in the intensive care unit blood-gas analyzer (Ciba Corning 865, Ciba Corning Diagnostics, Medfield, MA, U.S.A.). The analyzer measured at 37°C. Nursing staff from the intensive care unit, who had been taught to use the machine by support staff, performed the analyses. Samples were not stored on ice. We collected the following data: pH and partial pressure of carbon dioxide; blood levels of lactate, bicarbonate and ionized calcium. The bicarbonate concentration was calculated using the Henderson-Hasselbalch equation incorporating a carbon dioxide solubility coefficient of 0.0307 and an apparent overall dissociation constant for carbonic acid of 6.105.
For each data set, a further sample was drawn at the same time from the same arterial sampling point using a vacuum technique with lithium heparin tubes (Vacuette, Greiner Labortechnik, Kremsmunster, Austria). We included the data if the nurse recorded that the two samples were taken together. These samples were sent to the hospital core laboratory in the Division of Laboratory Medicine. Plasma underwent a multicomponent analysis (Hitachi 747, Roche Diagnostics, Sydney, N.S.W.). Scientific staff from the hospital clinical chemistry department analysed the samples. The samples were not stored on ice. We collected the following data: plasma concentrations of total carbon dioxide, sodium, potassium, magnesium, chloride, phosphate and albumin. Bicarbonate was estimated from the total carbon dioxide concentration from the enzymatic method with spectrophotometric detection ( Figure 2 ). The enzymatic assay is calibrated daily with 30 millimolar sodium bicarbonate.
To estimate the bicarbonate concentration from the strong-ion-gap equation we first calculated the anions formed from the weak acids albumin and phosphate. Figge Several known ions have been left out because of their micromolar concentrations: hydrogen, hydroxyl and carbonate ions 6 . Because bicarbonate anions have a single negative charge the concentration in mEq/l equals the concentration in mmol/l. Agreement between the three methods was analyzed using Bland-Altman analyses 7 . After reviewing clinical use of plasma bicarbonate concentrations, we proposed that bias greater than ±1 mmol/l and limits of agreement wider than bias ±2 mmol/l were clinically important 3, 8, 9 . We proposed to collect 100 pairs of data.
We estimated the precision effect of the combined measurement errors for each variable in the strongion-gap equation. The standard deviation and coefficient of variation (standard deviation divided by the mean) for each variable were collected from quality assurance data. The sum of twice the standard deviations was used to estimate the widest likely 95% confidence interval for bicarbonate estimates from strong-ion-gap calculations.
RESULTS
One hundred pairs of data were collected over six weeks in mid 2000. Data collection was limited by sample pairs not being drawn at the same time or failure to measure the required variables. We found that the agreement between all three methods fell outside our predetermined acceptable agreement of bias greater than ±1 mmol/l and limits of agreement wider than bias ±2 mmol/l (Figures 3  to 5 ). The agreement between the Henderson-Hasselbalch method and the enzymatic method was poor. The bias (mean difference) showed the enzymatic values to be less than the Henderson-Hasselbalch values. The agreement between the strong-ion-gap method and the other two methods was very poor, with wide limits of agreement and large biases. Of the three comparisons, the greatest bias was between the enzymatic and strong-ion-gap methods.
From the quality assurance data (Table 1) , the widest likely 95% confidence interval for each bicarbonate estimate from the strong-ion-gap equation was the bicarbonate estimate plus or minus 7.1 mmol/l.
DISCUSSION
We estimated plasma bicarbonate concentration in 100 blood samples from critically ill patients. We compared three methods: the Henderson-Hasselbalch, enzymatic, and strong-ion-gap. We found the strongest agreement between the Henderson-Hasselbalch and enzymatic methods. As in our previous findings 3 however, the agreement was poor. From the bias we again found that the enzymatic values were less than the Henderson-Hasselbalch values, the reverse of the expected relationship. There was very poor agreement between the strong-ion-gap and Henderson-Hasselbalch approaches, and the strong-ion-gap and enzymatic approaches.
The strong-ion-gap is an extension of the acidbase approach of the late Peter Stewart 4,6,10,11 . The In mmol/l the summary statistics with 95% confidence intervals in brackets are bias 2.1 (1.7 to 2.5), upper limit 5.9 (5.3 to 6.6), and lower limit -1.8 (-2.4 to -1.1). Henderson-Hasselbalch minus strong-ion-gap mmol/l Enzymatic minus strong-ion-gap mmol/l strong-ion-gap is calculated from the ionic contributions of Stewart's three independent variables: the strong ion difference, the partial pressure of carbon dioxide, and the total weak-acid concentration. The term strong-ion-gap is the most common name for the unknown anions. Strong-ion-gap is, however, a misnomer, because neither the boundaries of the gap nor the contents of the gap are necessarily strong ions. Unfortunately the term "anion gap" is in common use for a different but related quantity 9 .
The agreement between the Henderson-Hasselbalch and enzymatic methods was poor but the agreement was worse comparing the strong-ion-gap method to the other two methods. There are several possible causes for this.
The first possible cause for the poor agreement is unmeasured anions in the plasma. Previous workers have found a wide range of unmeasured anions. In the first paper describing the strong-ion-gap, Kellum and colleagues 11 found a mean strong-ion-gap of zero mEq/l for healthy people after exercise, 4.8 mEq/l in patients with sepsis, and 9.6 mmol/l in patients with liver disease. Gilfix and colleagues 12 found a mean concentration of unmeasured anions of 2 mEq/l in critically ill patients. Because in our previous study the Henderson-Hasselbalch method was up to 6 mmol/l greater than the enzymatic method, we were uncertain of the likely importance of unmeasured anions in this study.
We included critically ill patients from a general intensive care unit population, but excluded patients recovering from cardiac surgery. The mix of patients at our hospital is similar to many intensive care units from tertiary hospitals but includes more patients with acute spinal cord injuries and patients with liver failure. For our patient population the differences between strong-ion-gap results and the Henderson-Hasselbalch and enzymatic results suggest that the average concentration of unmeasured anions in the samples could have been around 10 mEq/l. The unmeasured anions were probably a mixture of three types of anions: strong anions such as sulphate 8 , multicarbon anions like acetate and glutamate acting as strong anions at physiological pH 13 , and anions from weak acids such as polygeline from Haemaccel (Hoechst Marion Roussel, Lane Cove, N.S.W.) 4, 14 .
The second possible cause for poor agreement is inaccuracy in the clinical chemistry assays due to bias or imprecision. By using many biochemical variables in the strong-ion-gap calculation, the inaccuracies, shown in Table 1 , were compounded. These compounded inaccuracies will affect the limits of agreement (precision) rather than the bias. From our calculation, the widest 95% confidence interval for the bicarbonate estimates from the strong-ion-gap will include values up to 7.1 mmol/l greater or less than the bicarbonate estimate. In the future, if we identify most or all of the unmeasured anions, the strong-ion-gap approach should have less bias in estimating bicarbonate, but with more variables the limits of agreement (precision) may become worse.
A third possible cause for the poor agreement is that the constants in the strong-ion-gap calculation maybe unstable in the critically ill. This cause for poor agreement would be aggravated by possible inaccuracies in the Henderson-Hasselbalch method due to unstable constants 1 or the enzymatic method due to carbon dioxide loss 2 .
We conclude that, for samples from critically ill patients, the strong-ion-gap method for estimating plasma bicarbonate concentration agrees very poorly with two established assays. We also confirm a previous finding that the established assays have poor agreement.
Two factors are needed to make the strong-ion-gap method more clinically useful: first, we need to identify and measure more of the currently unmeasured anions in patients' plasma; and second, clinical chemistry assays need to be more precise. We believe that possible inaccuracies in the established clinical methods of bicarbonate estimation may adversely affect patient care.
